glp 1 compounding pharmacies & GLP-1 Medicine: Weighing the Risks Microdose GLP FDA and Novo Nordisk Warned

Enzymatic production of -L-glutamyltaurine through the transpeptidation reaction of -glutamyltranspeptidase from Escherichia coli K-12

Given the significant differences in mechanism, evidence, regulatory status, and clinical indication, a direct head-to-head comparison of retatrutide and tesamorelin as interchangeable options is not clinically appropriate

Attributions Content: Matthew Rogan Figures: Matthew Rogan Proofreading: Connor Trotter, Dr Alice Banks, Bradley Brown, Jasmine Bird, Matthew Rogan References Mischley LK, Standish LJ, Weiss NS, Padowski JM, Kavanagh TJ, White CC, et al

The cumulative effect of age-related decline plus multiple drying medications plus GLP-1 effects can accelerate dental deterioration rapidly if unmanaged

We hope you have a meaningful and manageable day

This finding appears to translate to humans given that the GIPR mono-agonist LY3537021 has been reported to reduce body weight in healthy volunteers and patients with T2D [15]